Testing effectiveness (Phase 2)Study completedNCT04225923What this trial is testingKidney Transplant Recipients at High-Risk of Cytomegalovirus InfectionWho this might be right forCytomegalovirus Disease Nobelpharma 87
Large-scale testing (Phase 3)Study completedNCT03123627What this trial is testingRandomized Clinical Trial, Open, Multicenter Parallel, no Suspension Inferiority Prophylactic Treatment With Valganciclovir in Kidney Transplant CMV-seropositive Cellular Immunity to Develop CD8 + CMV-specific Treatment After Induction Thymoglobulin.Who this might be right forKidney Transplant Infection Maimónides Biomedical Research Institute of Córdoba 150
Large-scale testing (Phase 3)Study completedNCT00002145What this trial is testingPhase III Multicenter, Open-Label, Randomized Trial of Induction Versus Induction Plus Maintenance Foscarnet ( Foscavir ) Therapy for Gastrointestinal CMV DiseaseWho this might be right forHIV InfectionsGastrointestinal Diseases Astra USA 145
Testing effectiveness (Phase 2)Study completedNCT01325636What this trial is testingInjection of CD4 and CD8 + T Cells Anti-Cytomegalovirus (CMV) or Anti-adenovirusWho this might be right forCytomegalovirus InfectionsAdenovirus Infections Assistance Publique - Hôpitaux de Paris 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT04116411What this trial is testingA Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma PatientsWho this might be right forGlioblastoma Multiforme Cecilia Soderberg-Naucler 220
Testing effectiveness (Phase 2)Study completedNCT00000712What this trial is testingA Multicenter, Double Blind, Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4+ Counts Less Than 200 Cells/mm3Who this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 400
Testing effectiveness (Phase 2)Study completedNCT05575492What this trial is testingMRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of AgeWho this might be right forCytomegalovirus ModernaTX, Inc. 873
Not applicableStudy completedNCT02684734What this trial is testingPrevalence of Cytomegalovirus Infection in Patients With Quiescent Ulcerative ColitisWho this might be right forUlcerative ColitisCytomegalovirus Infections University of British Columbia 50
Not applicableLooking for participantsNCT07335874What this trial is testingOverview of Targeted Screening for Congenital Infection Guided by Neonatal Hearing ScreeningWho this might be right forNeonatal Hearing Loss University Hospital, Strasbourg, France 450
Testing effectiveness (Phase 2)Looking for participantsNCT06853184What this trial is testingStudy Evaluating the Efficacy and Safety of ArtesunateWho this might be right forCMV Infection Amivas Inc. 90
Post-approval studies (Phase 4)Study completedNCT01895049What this trial is testingComparison Between Two Tacrolimus-based Immunosuppressant Regimens and Induction With Thymoglobulin in Kidney Transplants From Deceased Donors With Expanded CriteriaWho this might be right forKidney TransplantationCytomegalovirus Helio Tedesco Silva Junior 171
Early research (Phase 1)Study completedNCT00002096What this trial is testingA Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and DidanosineWho this might be right forCytomegalovirus InfectionsHIV Infections Hoffmann-La Roche 24
Not applicableEnded earlyNCT00302029What this trial is testingCMV Infection in Adolescent MalesWho this might be right forCytomegalovirus Infections National Institute of Allergy and Infectious Diseases (NIAID) 411
Testing effectiveness (Phase 2)Study completedNCT00001061What this trial is testingComparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDSWho this might be right forCytomegalovirus RetinitisHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 167
Early research (Phase 1)Study completedNCT00880789What this trial is testingSafety, Toxicity and MTD of One Intravenous IV Injection of Donor CTLs Specific for CMV and AdenovirusWho this might be right forCytomegalovirus InfectionAdenovirus Infection Baylor College of Medicine 9
Testing effectiveness (Phase 2)Study completedNCT00530218What this trial is testingGanciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow TransplantWho this might be right forMyelodysplastic/Myeloproliferative Neoplasm, UnclassifiableLeukemiaLymphoma+3 more City of Hope Medical Center 61
Large-scale testing (Phase 3)Looking for participantsNCT05319353What this trial is testingEvaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)Who this might be right forCytomegalovirus (CMV) Takeda 80
Not applicableNot Yet RecruitingNCT07141095What this trial is testingA Prospective Single-Arm Observational Study of Maribavir for the Treatment of Post Hematopoietic Stem Cell Transplantation Cytomegalovirus InfectionWho this might be right forInfections, Cytomegalovirus Institute of Hematology & Blood Diseases Hospital, China 17
Not applicableStudy completedNCT00002142What this trial is testingAn Open-Label Study of the Safety and Efficacy of Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDSWho this might be right forCytomegalovirus RetinitisHIV Infections Gilead Sciences 100
Post-approval studies (Phase 4)Study completedNCT00431353What this trial is testingVICTOR Study - A Study of Valcyte (Valganciclovir po) Compared to Ganciclovir iv in Patients With Cytomegalovirus (CMV) Disease Who Are Solid Organ Transplant RecipientsWho this might be right forCytomegalovirus Infections Hoffmann-La Roche 325